icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
Safety and Efficacy of Glecaprevir/Pibrentasvir for the Treatment
of HCV Genotype 1-6: Results of the HCV-TARGET Study
 
 
 

0415191

0415192

0415193

0415194

0415195

0415196